Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden

@article{Zller2012RiskOP,
  title={Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden},
  author={Bengt Z{\"o}ller and Xinjun Li and Jan Sundquist and Kristina Sundquist},
  journal={The Lancet},
  year={2012},
  volume={379},
  pages={244-249}
}
BACKGROUND Some autoimmune disorders have been linked to venous thromboembolism. We examined whether there is an association between autoimmune disorders and risk of pulmonary embolism. METHODS We followed up all individuals in Sweden without previous hospital admission for venous thromboembolism and with a primary or secondary diagnosis of an autoimmune disorder between Jan 1, 1964, and Dec 31, 2008, for hospital admission for pulmonary embolism. We obtained data from the MigMed2 database… Expand
Risk of pulmonary embolism and deep venous thrombosis in patients with asthma: a nationwide case−control study from Sweden
TLDR
The inflammation conferred by asthma seems to have systemic (and not just local) prothrombotic effects with increased risk of both DVT and PE in patients with asthma. Expand
Venous Thromboembolism in Patients With Autoimmune Disorders: Findings From the RIETE Registry
TLDR
Patients with autoimmune disorders are at an increased risk of venous thromboembolism (VTE) and patients with or without autoimmune disorders had similar rates of VTE recurrences or major bleeding during the course of anticoagulation, according to the presence or absence of autoimmune disorders. Expand
The risk of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a UK population-based outpatient cohort study
TLDR
This population-based study indicates an increased risk of PE and DVT inRA, supporting increased monitoring of venous-thromboembolic complications and risk factors in RA, regardless of hospitalisation. Expand
Risk of venous thromboembolism among hospitalizations of adults with selected autoimmune diseases
TLDR
The presence of a diagnosis of AIHA, ITP, RA, and SLE was associated with an increased likelihood of having a VTE diagnosis among the group of all non-maternal adult hospitalizations. Expand
The risk of pulmonary embolism and deep venous thrombosis in systemic lupus erythematosus: A general population-based study.
TLDR
These findings provide population-based evidence that patients with SLE have a substantially increased risk of VTE, especially in the first year after SLE diagnosis. Expand
Risk of Recurrent Venous Thromboembolism in Autoimmune Diseases: A Systematic Review of the Literature
TLDR
The overall VTE risk profile, lower effectiveness of anticoagulants, and the observation that Immunosuppression lowered risk of recurrence in patients with Behcet's disease seem to warrant immunosuppressant therapy over antICOagulation as a first consideration when preventing VTE recurrence In patients with autoimmune diseases. Expand
Risk of Venous Thromboembolic Events in Pregnant Patients With Autoimmune Diseases
  • Nathalie Bleau, V. Patenaude, H. Abenhaim
  • Medicine
  • Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
  • 2016
TLDR
Most autoimmune diseases considerably increase the risk of VTE in pregnant women, particularly those with systemic lupus erythematosus and dermatomyositis, and thromboprophylaxis may be considered in pregnancies with autoimmune disease. Expand
Risk of venous thromboembolism in rheumatoid arthritis, and its association with disease activity: a nationwide cohort study from Sweden
TLDR
This study demonstrates a strong association between clinical RA disease activity measured by DAS28 ESR and the risk of VTE, and can be used as an additional tool for VTE risk stratification in patients with RA. Expand
The Risk of Deep Venous Thrombosis and Pulmonary Embolism in Primary Sjögren Syndrome: A General Population-based Study
TLDR
These findings provide population-based evidence that patients with pSS have a substantially increased risk of VTE, especially within the first year after SS diagnosis, and further research into the involvement of monitoring and prevention of Vte in SS may be warranted. Expand
Sarcoidosis and risk of venous thromboembolism: A systematic review and meta-analysis.
TLDR
This study demonstrated a statistically significant increased VTE risk among patients with sarcoidosis, as well as three eligible studies identified and included in the data analysis. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 23 REFERENCES
The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study.
TLDR
IBD patients have a threefold increased risk of developing deep venous thrombosis (DVT) and pulmonary embolism (PE) from a population-based database of IBD patients and, to compare the incidence rates to that of an age, gender and geographically matched population control group. Expand
Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study
BackgroundVenous thromboembolism (VTE) is a common complication during and after a hospital admission. Although it is mainly considered a complication of surgery, it often occurs in people who haveExpand
Increased risk of pulmonary embolism among patients with hyperthyroidism: a 5‐year follow‐up study
TLDR
An increased risk of pulmonary embolism (PE) is found in patients with hyperthyroidism during a 5‐year follow‐up period, and Clinicians should be aware of this increased risk. Expand
Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER)
TLDR
Data from ICOPER provide rates and highlight adverse prognostic categories that will help in planning of future trials of high-risk PE patients and highlight significant prognostic factors associated with death. Expand
Inflammatory Bowel Disease Promotes Venous Thrombosis Earlier in Life
  • O. Grip
  • Medicine
  • Scandinavian journal of gastroenterology
  • 2000
TLDR
A large number of patients with inflammatory bowel disease had venous thrombosis earlier in life than non-IBD patients, and although factor V mutation may contribute to thromBosis, IBD acts as a trigger through mechanisms that still remain unexplained. Expand
Risk of thromboembolism in 14 000 individuals with coeliac disease
TLDR
This study found a statistically significantly positive association between CD and VTE and this modest association might be explained by a combination of surveillance bias and chronic inflammation. Expand
Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?
TLDR
It seems that TE is a specific feature of IBD as neither rheumatoid arthritis, another chronic inflammatory disease, nor coeliac disease, another Chronic bowel disease, had an increased risk of TE. Expand
Risk of venous thromboembolism with rheumatoid arthritis.
TLDR
A heightened awareness of the risks for VTE and a lower threshold for evaluation of patients for possible DVT or PE would be appropriate in caring for hospitalized patients with rheumatoid arthritis. Expand
Morbidity and Mortality in Systemic Lupus Erythematosus During a 10-Year Period: A Comparison of Early and Late Manifestations in a Cohort of 1,000 Patients
TLDR
Most of the SLE inflammatory manifestations appear to be less common after a long-term evolution of the disease, probably reflecting the effect of therapy as well as the progressive remission of the Disease in many patients. Expand
Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study.
TLDR
The primary univariate analysis showed that the presence of an acute infectious disease, age older than 75 years, cancer, and a history of VTE were statistically significantly associated with an increased VTE risk. Expand
...
1
2
3
...